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Abstract N-Atracotoxins (N-ACTXs) are peptide toxins isolated
from the venom of Australian funnel-web spiders that slow
sodium current inactivation in a similar manner to scorpion
K-toxins. We have isolated and determined the amino acid
sequence of a novel N-ACTX, designated N-ACTX-Hv1b, from
the venom of the funnel-web spider Hadronyche versuta. This
42 residue toxin shows 67% sequence identity with N-ACTX-
Hv1a previously isolated from the same spider. Under whole-cell
voltage-clamp conditions, the toxin had no effect on tetrodotoxin
(TTX)-resistant sodium currents in rat dorsal root ganglion
neurones but exerted a concentration-dependent reduction in
peak TTX-sensitive sodium current amplitude accompanied by a
slowing of sodium current inactivation similar to other N-ACTXs.
However, N-ACTX-Hv1b is approximately 15^30-fold less
potent than other N-ACTXs and is remarkable for its complete
lack of insecticidal activity. Thus, the sequence differences
between N-ACTX-Hv1a and -Hv1b provide key insights into the
residues that are critical for targeting of these toxins to
vertebrate and invertebrate sodium channels.
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1. Introduction
Australian funnel-web spiders (Araneae: Hexathelidae:
Atracinae) belong to the infraorder Mygalomorphae and are
distributed mainly along the southeastern seaboard. The fun-
nel-web spider sub-family, Atracinae, comprises around 35
species divided between the genera Atrax and Hadronyche.
A variety of peptides known as atracotoxins (ACTXs) have
been isolated from the venom of these spiders, particularly the
Blue Mountains funnel-web spider Hadronyche versuta (Rain-
bow). These toxins include the g-ACTXs, which selectively
inhibit insect voltage-gated calcium channels [5,25], ACTX-
Hvf17, a peptide with strong sequence homology to mamba
intestinal toxin [23], and more recently the insecticidal
J-ACTXs with as yet unknown molecular targets (G.F.K. et
al., unpublished results). However, the potentially lethal tox-
ins responsible for the major primate-speci¢c symptoms of
envenomation, N-ACTX-Hv1 (formerly versutoxin) from
H. versuta [2] and its homologue N-ACTX-Ar1 (formerly ro-
bustoxin) from Atrax robustus [21], have been shown to target
the voltage-gated sodium channel.
N-ACTX-Ar1 and -Hv1 are highly homologous 42 residue
peptides with 83% amino acid identity and only two non-con-
served substitutions. They show no signi¢cant sequence ho-
mology with any presently known neurotoxins. The toxins
have a high proportion of basic residues and they are cross-
linked by four conserved intramolecular disul¢de bonds (see
Fig. 2). Recent work has revealed that both N-ACTX-Ar1 and
-Hv1 exert their neurotoxic actions by slowing tetrodotoxin
(TTX)-sensitive sodium current inactivation [14,15], an action
similar to scorpion K-toxins and sea anemone toxins [8,22].
Indeed, nanomolar concentrations of N-ACTX-Ar1 and -Hv1
completely inhibit the binding of the classical scorpion K-tox-
ins Lqh II (from the scorpion Leiurus quinquestriatus he-
braeus) and Aah II (from the scorpion Androctonus australis
hector) to neurotoxin receptor site 3 on rat brain sodium
channels [11,12]. Interestingly, however, N-ACTXs also inhibit
the binding of the scorpion K-insect toxin LqhKIT to cock-
roach neuronal membranes and produce a delayed contractile
paralysis in insects similar to LqhKIT. Thus, N-ACTXs repre-
sent a new class of toxins which bind to both mammalian and
insect sodium channels at sites similar to, or partially over-
lapping with, neurotoxin receptor site 3.
The three-dimensional solution structures of N-ACTX-Hv1
[4] and N-ACTX-Ar1 [17] have been determined using NMR
spectroscopy. Both display a small triple-stranded antiparallel
L-sheet and a cystine knot which places them in a class of
toxins and inhibitory polypeptides with an ‘inhibitor cystine
knot’ [18]. Interestingly, the protein sca¡old is distinctly dif-
ferent to that of the scorpion K-toxins Aah II [6] and LqhKIT
[24] and the sea anemone toxin anthopleurin-B [13] despite
similar actions of all three toxins on sodium current inactiva-
tion [3,8,22]. However, the three groups of toxins share a
number of topologically related anionic and cationic residues.
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This allowed the construction of a plausible molecular model,
based on electrostatic complementarity, to explain how all of
these toxins might interact with a patch of charged residues
within the S3^S4 loop of domain IV of the voltage-gated
sodium channel [19].
Here, we describe the isolation and pharmacological char-
acterisation of a novel N-ACTX from the venom of H. versuta.
This toxin is a much less potent modulator of vertebrate so-
dium channels that previously characterised N-ACTXs and, in
marked contrast to N-ACTX-Hv1 and N-ACTX-Ar1, it com-
pletely lacks insecticidal activity. The actions of this toxin
provide further support for the role of N-terminal cationic
residues in determining phylogenetic speci¢city.
2. Materials and methods
2.1. Toxin puri¢cation and sequencing
Venom was collected from both male and female Blue Mountains
funnel-web spiders (H. versuta) and fractionated using reverse-phase
high performance liquid chromatography (rpHPLC) exactly as re-
ported previously [3]. Prior to biochemical analyses, N-ACTX-Hv1b
(peak b in Fig. 1B) was further puri¢ed on an analytical C18 rpHPLC
column using a gradient of 5^29% CH3CN/0.1% tri£uoroacetic acid
(TFA) over 5 min, then 29^32% CH3CN/0.1% TFA over 15 min, at a
£ow rate of 0.75 ml/min. Puri¢ed toxin was collected, lyophilised and
stored at 320‡C until required. Toxin quanti¢cation was performed
using a bicinchoninic acid Protein Assay kit (Pierce, Rockford, IL,
USA) using bovine serum albumin as a standard. Absorbances were
read at 570 nm on a Bio-Rad Model 450 microplate reader. The
molecular mass was determined by electrospray ionisation mass spec-
trometry.
In preparation for amino acid sequencing, the toxin was reduced
and cysteine residues were pyridylethylated as described previously [3].
The reduced, pyridylethylated toxin was puri¢ed using rpHPLC as
described previously [3], then the entire peptide sequence was obtained
from a single sequencing run on an Applied Biosystems/Perkin Elmer
Procise 492 cLC protein sequencer.
2.2. Rat vas deferens bioassay
Peptide toxins were assayed for their e¡ect in rat vas deferens nerve
muscle tissue as described previously [3]. Twitch contractions of these
muscles were elicited by ¢eld stimulation of the nerve [3], and mus-
cular contractions were recorded using an isometric force transducer
and displayed on a £atbed chart recorder. Contractions of each tissue
were recorded in the absence of additives or following injection of
peptides (10^20 Wl in water) directly into the bath bu¡er. N-ACTX-
Hv1 (100 nM) was used as a positive control.
2.3. Electrophysiological studies
Acutely dissociated dorsal root ganglion (DRG) neurones were pre-
pared from 4^12 day old Wistar rats and maintained in short-term
primary culture using the method described by Nicholson et al. [15].
Voltage-clamp recordings were made with whole-cell patch-clamp
techniques [7] using an AxoPatch 200A patch-clamp ampli¢er
(Axon Instruments, Foster City, CA, USA). Micropipettes were
pulled from borosilicate glass capillary tubing (Corning 7052 Glass,
Warner Instruments) and had d.c. resistances of 0.8^2.0 M6.
To record macroscopic sodium currents, micropipettes were ¢lled
with a solution of the following composition (in mM): CsF 135, NaCl
10, N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES) 5,
with the pH adjusted to 7.0 with 1 M CsOH. The external bathing
solution contained (in mM): NaCl 30, MgCl2 1, CaCl2 1.8, CsCl 5,
KCl 5, D-glucose 25, HEPES 5, tetraethylammonium (TEA) chloride
20, tetramethylammonium chloride 70, with the pH adjusted to 7.4
with 1 M TEA hydroxide.
The osmolarity of both solutions was adjusted to 290^300 mOsm/l
with sucrose to reduce osmotic stress. The external solution was ap-
plied to the perfusion chamber via a gravity-fed perfusion system and
the £ow rate maintained at 0.5 ml/min using a Gilmont £owmeter
(Barrington, IL, USA). Data were recorded at room temperature
(22^25‡C) which did not £uctuate more than 1‡C during the course
of an experiment. In all voltage-clamp experiments, the holding po-
tential was 380 mV and the sodium concentration of the external
solution was reduced to 30 mM to improve series resistance compen-
sation and to avoid saturation in the recording system [16]. Inverted
voltage-clamp command pulses were applied to the bath through a
Ag/AgCl pellet/3 M KCl-agar bridge. The liquid junction potential
between internal and external solutions was approximately 36 mV,
and all data were compensated for this value.
Large round light DRG cells with diameters of 20^40 Wm were
selected for experiments. Larger cells from older animals tended to
express fast TTX-sensitive sodium currents whilst smaller cells tended
to express predominantly slow TTX-resistant sodium currents [20]. In
those experiments that assessed the actions of N-ACTX-Hv1b on
TTX-resistant currents, 200 nM TTX was applied in the external so-
lution to eliminate any residual TTX-sensitive sodium currents. Only
those cells which exhibited less than 10% TTX-resistant sodium cur-
rent, as determined from di¡erences in the steady-state sodium chan-
nel inactivation pro¢le, were used to determine the actions of
N-ACTX-Hv1b on TTX-sensitive sodium currents. After breaking
through the membrane, experiments did not commence for a period
of 20^30 min to allow for the complete block of calcium and potas-
sium currents and any fast time-dependent shifts in steady-state so-
dium channel inactivation. The experiments used in this study were
rejected if there were large leak currents or currents showed signs of
poor space clamping such as an abrupt activation of currents upon
relatively small depolarising pulses.
Stimulation and recording were both controlled by a pClamp0 data
acquisition system (Axon Instruments). Data were ¢ltered at 5 kHz
(4 pole low-pass Bessel ¢lter) and digital sampling rates were between
15 and 25 kHz depending on the voltage protocol length. Leakage and
capacitive currents were digitally subtracted with P^P/4 procedures [1]
and series resistance compensation was set at s 80% for all cells. Data
analyses were performed o¡-line following completion of the experi-
ment. Mathematical curve ¢tting employed algorithms available in
KaleidaGraph0 for Macintosh using a non-linear least squares meth-
od.
The curve ¢ts for the I/V data were obtained using the following
equation:
INa  gmax 13 11 expV3V1=2=s
  
V3V rev 1
where INa is the amplitude of the peak Na current at a given test
potential, V ; gmax is the maximal Na conductance; V1=2 is the volt-
age at half-maximal activation; s is the slope factor and Vrev is the
reversal potential.
The ¢tted curves for steady-state sodium current inactivation (h8)
were obtained using the following form of the Boltzmann equation:
h8  13C1 expV3V 1=2=k  C 2
where V1=2 is the voltage at half-inactivation; k is the slope factor; V
is the test voltage and C is a constant or non-inactivating fraction
(usually zero in controls).
Comparisons of two sample means were made using a paired Stu-
dent’s t-test. A test was considered to be signi¢cant when P6 0.05. All
data are presented as mean þ S.E.M.
2.4. Insect toxicity assays
Insect toxicity was determined by lateroventral thoracic injection of
N-ACTX-Hv1b into third^fourth instar cricket nymphs (Acheta do-
mesticus Linnaeus), as described previously [2], at doses up to 2000
pmol/g. Control crickets were injected with insect saline. Insects were
monitored for 72 h following injection.
3. Results
3.1. Venom separation and toxin puri¢cation
Fig. 1A shows a rpHPLC chromatogram of pooled male
and female H. versuta venom. The elution pro¢le was repro-
ducible for batches of venom, although several minor peaks
that were evident in the mixed venom were not present in
venom obtained exclusively from female spiders. We previ-
ously estimated that the venom contains approximately 100
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compounds, since mass spectral analyses revealed that some
peaks which appear to be homogeneous by rpHPLC are ac-
tually a mixture of several components [25].
The boxed peak highlighted in Fig. 1A was found to en-
hance muscular contractions as well as cause spontaneous
contractions of isolated rat vas deferens smooth muscle
(data not shown) similar to those elicited by N-ACTX-Ar1
[9]. Further puri¢cation of this fraction using C18 rpHPLC
with a shallow acetonitrile gradient yielded two distinct com-
ponents. The minor peak, labeled peak b in Fig. 1B, was
subsequently shown to be the active component in the rat
vas deferens assay. The molecular mass of peak b was deter-
mined to be 4770 Da using electrospray mass spectrometry.
3.2. Determination of amino acid sequence
Peak b was reduced and the cysteines pyridylethylated in
preparation for N-terminal amino acid sequencing. This was
done for two reasons. First, mass spectrometric analysis of the
reduced and pyridylethylated toxin reveals the number of cys-
teine residues in the toxin as the mass increases by 106 Da for
every cysteine residue modi¢ed with 4-vinylpyridine. Sec-
ondly, unlike unmodi¢ed phenylthiohydantoin (PTH)-Cys,
PTH-Cys with a pyridylethylated sidechain is stable during
automated N-terminal amino acid sequencing and therefore
allows positive identi¢cation of Cys residues.
Mass spectral analysis of the pyridylethylated toxin indi-
cated that it contained eight cysteine residues. The amino
acid sequence of the toxin (see Fig. 2), obtained in a single
sequencing run without the need to resort to proteolytic di-
gestion, revealed that it contains 42 residues, including eight
cysteines. The predicted mass of 4770.5 Da for the fully oxi-
dised peptide, in which the eight cysteine residues form four
disul¢de bonds, is consistent with the mass spectral analysis.
A search for homologous proteins in the protein and DNA
databases revealed signi¢cant homology with two other Aus-
tralian funnel-web spider toxins, N-ACTX-Hv1 [2] isolated
from the same spider venom, and N-ACTX-Ar1 [21] isolated
from the venom of the Sydney funnel-web spider, A. robustus.
The sequence shows conservation in the number and spacing
of cysteine residues. When conservative substitutions are tak-
en into consideration, the homology with N-ACTX-Hv1 and
N-ACTX-Ar1 is 79% and 76%, respectively. The toxin has
14 amino acid substitutions relative to N-ACTX-Hv1, whereas
N-ACTX-Hv1 and N-ACTX-Ar1 only di¡er at seven positions
(see Fig. 2).
Based on the sequence homology and functional similarities
(see below) with N-ACTX-Hv1, we have named the toxin
N-ACTX-Hv1b in accordance with the nomenclature previ-
ously described for toxins isolated from Australian funnel-
web spiders [5]. Accordingly, in the future, N-ACTX-Hv1
should more correctly be referred to as N-ACTX-Hv1a. The
sequence of N-ACTX-Hv1b has been deposited in the SWISS-
PROT databank under accession number P81885.
3.3. E¡ects of N-ACTX-Hv1b on voltage-gated sodium currents
Under voltage-clamp conditions, N-ACTXs have been pre-
viously shown to cause a concentration-dependent reduction
in peak TTX-sensitive sodium current amplitude and slowing
Fig. 1. rpHPLC chromatogram of pooled male and female H. versu-
ta venom. (A) Screening of venom fractions revealed that the boxed
peak caused spontaneous contractions of isolated rat vas deferens.
(B) Further rpHPLC puri¢cation of this fraction yielded two peaks,
the smaller of which (peak b) was found to be the active component
in the rat vas deferens assay.
Fig. 2. Comparison of the amino acid sequences of N-ACTX-Hv1a, N-ACTX-Hv1b and N-ACTX-Ar1. Identical residues are shaded in black
and conservatively substituted residues are shaded in grey. The disul¢de bonding pattern for the strictly conserved cysteine residues determined
for N-ACTX-Hv1a [4] and N-ACTX-Ar1 [17] is indicated below the sequences; it is assumed that N-ACTX-Hv1b has the same disul¢de bonding
pattern. Secondary structure for N-ACTX-Hv1a is shown at the top of the ¢gure where shaded squares represent L-turns, black arrows repre-
sent L-strands and the grey cylinder represents a 310 helix [4]. N-ACTX-Hv1b clearly belongs to the N-ACTX family of funnel-web toxins that
modulate voltage-gated sodium channels. The percentage identity and homology with N-ACTX-Hv1b is shown to the right of the sequences.
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of sodium current inactivation [14,15]. Fig. 3A^C shows the
e¡ect of increasing concentrations of N-ACTX-Hv1b on TTX-
sensitive sodium currents. At 300 nM, N-ACTX-Hv1b reduced
peak TTX-sensitive sodium current amplitude by 17.3 þ 4.9%
(n = 7) and slowed the rate of TTX-sensitive sodium current
inactivation. Analysis of the toxin e¡ect on inactivation was
estimated by measuring the current remaining after 50 ms
following a step depolarisation to indicate the proportion of
channels with permanently modi¢ed inactivation. At 310 mV,
the remaining current was 11.3 þ 2.6% (n = 7) of control peak
current. Since the threshold concentration for these actions on
TTX-sensitive sodium channels in DRG neurones was found
to be approximately 30 nM for N-ACTX-Hv1b and 1^2 nM
for N-ACTX-Hv1a [15], we conclude that N-ACTX-Hv1b is
15^30 times less potent than N-ACTX-Hv1a on TTX-sensitive
sodium channels. Similar to N-ACTX-Hv1a, the reduction in
sodium current amplitude and slowing of current inactivation
produced by N-ACTX-Hv1b was partially reversible after pro-
longed washing with toxin-free solution. In marked contrast
to its action on TTX-sensitive sodium channels N-ACTX-
Hv1b (300 nM), like other N-ACTXs [14,15], failed to signi¢-
cantly alter either the amplitude or time course of TTX-resis-
tant sodium currents (Fig. 3D).
3.4. E¡ects of N-ACTX-Hv1b on the voltage dependence of
sodium channel activation
Previous studies have shown that N-ACTXs shift the thresh-
old of activation of TTX-sensitive sodium currents in the
hyperpolarising direction [14,15]. Analysis of the I/V relation-
ship of TTX-sensitive sodium current in the presence of 300
nM N-ACTX-Hv1b (Fig. 2D) revealed similar 10 mV hyper-
polarising shifts in the threshold of sodium channel activation.
Data were normalised and ¢tted using a single Boltzmann
distribution. N-ACTX-Hv1b only caused a modest 6.3 mV
hyperpolarising shift in the voltage midpoint (V1=2) from
338.4 þ 1.7 mV to 344.7 þ 3.2 mV (n = 5) with no change in
the slope factor s. Fig. 4E also shows that there was no alter-
ation in reversal potential. These changes could not be ex-
plained by spontaneous time-dependent shifts in the voltage
dependence of activation, which in general are 6 5 mV in
DRG neurones (G. Nicholson, unpublished results).
3.5. E¡ects of N-ACTX-Hv1b on the voltage dependence of
steady-state sodium channel inactivation (hr)
It has previously been noted that N-ACTXs shift the steady-
state sodium channel inactivation curve (hr/V) in the hyper-
polarising direction and produce a non-inactivating compo-
nent at depolarised prepulse test potentials [14,15]. To quan-
titate changes in the voltage dependence of steady-state
sodium channel inactivation produced by N-ACTX-Hv1b,
measurements were made with a standard two-pulse protocol
as detailed in Fig. 5. Peak sodium currents recorded during
each test pulse were normalised to the maximum peak current
and plotted against the conditioning prepulse potential.
Curves were then ¢tted using Eq. 2. As for N-ACTX-Hv1a
and -Ar1, N-ACTX-Hv1b caused a signi¢cant 9 mV hyper-
polarising shift in the voltage at which half the sodium chan-
nels were inactivated (V1=2) from 358.0 þ 0.7 mV to
367.1 þ 0.8 mV (paired Student’s t-test, P6 0.02, n = 4) with
no change in the slope factor. In addition, 300 nM N-ACTX-
Hv1b exhibited a classical non-inactivating component
(8.6 þ 1.2% of the maximal sodium current, determined from
C in Eq. 2) at prepulse test potentials more depolarised than
340 mV.
3.6. Insecticidal potency of N-ACTX-Hv1b
N-ACTX-Hv1a was previously shown to be a moderately
potent insecticidal toxin, with an LD50 of 770 pmol/g in house
crickets (A. domesticus) [11]. Furthermore, N-ACTX-Hv1a
caused contractile paralysis at signi¢cantly lower doses
Fig. 3. E¡ects of N-ACTX-Hv1b on TTX-sensitive and TTX-resistant sodium currents in rat DRG neurones. Superimposed current traces re-
corded following a depolarisation to 310 mV from a holding potential of 380 mV before (unlabeled) and 10 min after (labeled) the addition
of toxin. (A^C) E¡ects of: (A) 50 nM, (B) 100 nM and (C) 300 nM N-ACTX-Hv1b on TTX-sensitive sodium currents. Note the slowed sodium
current inactivation kinetics; insets in (A^C) show the magni¢ed peak TTX-sensitive sodium currents. (D) E¡ects of 300 nM N-ACTX-Hv1b on
TTX-resistant sodium currents elicited by the same stimulus protocol. Both current responses were recorded in the presence of 200 nM TTX to
eliminate residual TTX-sensitive sodium currents.
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(PD50 = 200 pmol/g), with the higher LD50 re£ecting the fact
that most crickets recover from the contractile paralysis at
doses near or below the PD50 [11]. Surprisingly, no adverse
e¡ects (i.e. neither paralysis nor death) were observed in crick-
ets in the 72 h following injection of N-ACTX-Hv1b at doses
up to 2000 pmol/g (i.e. 10 times the PD50 for N-ACTX-Hv1a).
Thus N-ACTX-Hv1b completely lacks insecticidal activity in
the same assay system despite strong sequence similarity with
N-ACTX-Hv1a.
4. Discussion
We recently embarked on a rational screening of all pep-
tidic components in the venom of H. versuta (G.F.K. et al.,
unpublished results). Initial screening of crude venom frac-
tions using a rat vas deferens bioassay revealed a fraction
that produced spontaneous contractions similar to those
seen with N-ACTX-Hv1a previously isolated from the venom
of the same spider. As described here, further puri¢cation of
Fig. 4. Typical e¡ects of N-ACTX-Hv1b on the current^voltage (I/V) relationship. Families of sodium currents were evoked by a series of 50
ms depolarisations from 380 to +70 mV in 5 mV steps applied every 10 s from a holding potential of 380 mV. Left-hand panels show e¡ects
on TTX-sensitive sodium currents while right-hand panels show e¡ects on TTX-resistant sodium currents recorded in the presence of 200 nM
TTX. (A^D) Families of sodium currents before (A,B) and after (C,D) application of 300 nM N-ACTX-Hv1b. For clarity, sodium currents re-
corded in 10 mV steps are presented. Note that the inactivation kinetics of both inward and outward currents are slowed and incomplete in
(C) only. (E,F) Peak (circles) and late (triangles) I/V relationships are shown before (empty symbols) and following (¢lled symbols) a 10 min
perfusion with 300 nM N-ACTX-Hv1b. Late currents were measured at the end of each 50 ms depolarising test pulse. Peak and late currents
were ¢tted according to Eq. 1 described in Section 2.
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the crude venom fraction and subsequent N-terminal sequenc-
ing showed that the active component, which we have desig-
nated N-ACTX-Hv1b, corresponds to a 42 residue peptide of
molecular weight 4770 Da which is clearly a homologue of
N-ACTX-Hv1a.
Given that previously characterised N-ACTXs are potent
modulators of sodium channel inactivation [14,15], we char-
acterised the mode of action of N-ACTX-Hv1b on sodium
channel gating and kinetics. The ¢ndings of this study dem-
onstrate that this novel toxin has selective e¡ects on TTX-
sensitive sodium currents including: (a) a slowing of channel
inactivation; (b) shifts in the voltage dependence of activa-
tion; and (c) a hyperpolarising shift in steady-state inactiva-
tion (hr). In contrast, TTX-resistant sodium channel gating
and kinetics remained una¡ected.
The main action of N-ACTX-Hv1b is to considerably slow
TTX-sensitive sodium channel inactivation as evidenced by a
steady-state current maintained during depolarising test
pulses. Moreover, in the presence of N-ACTX-Hv1b, a small
but signi¢cant portion of TTX-sensitive sodium currents (8%)
failed to inactivate even with prolonged large depolarising
prepulses to +10 mV for 1 s. N-ACTX-Hv1b also produced
a 9 mV hyperpolarising shift in the voltage dependence of
steady-state inactivation (hr) as a consequence decreasing
peak TTX-sensitive sodium current at holding potentials of
380 mV (see Fig. 3). This is most likely the result of a reduc-
tion in the availability of channels at membrane potentials of
380 mV since the maximum peak inward current recorded
from holding potentials of 3135 mV is not signi¢cantly re-
duced (see Fig. 5A). N-ACTX-Hv1b also altered the voltage
dependence of TTX-sensitive sodium channel activation by
shifting the threshold of activation (Fig. 4).
These actions, especially the slowing of sodium current in-
activation in the absence of large shifts in the voltage depen-
dence of activation or profound slowing of deactivation, in-
dicates that N-ACTX-Hv1b acts in a manner similar to
scorpion K-toxins, sea anemone toxins and previously charac-
terised N-ACTXs that bind to neurotoxin receptor site 3.
These actions suggest that N-ACTX-Hv1b inhibits conversion
of TTX-sensitive sodium channels from the open state to the
inactivated state, thus allowing a fraction of the sodium cur-
rent to remain at membrane potentials where inactivation is
normally complete. This is qualitatively similar to other
N-ACTXs, although N-ACTX-Hv1b appears to be approxi-
mately 15^30-fold less potent in its modulation of sodium
channel gating and kinetics.
Fig. 5. E¡ects of N-ACTX-Hv1b on steady-state TTX-sensitive sodium current inactivation (hr). Steady-state inactivation was determined using
the two-pulse protocol shown in the inset. Conditioning prepulse voltages of 1 s duration ranging from 3135 to +10 mV in 5 mV steps were
delivered every 10 s. (A) Typical current traces obtained following a 50 ms test pulse to 310 mV subsequent to prepulse potentials of 3130,
370 and 330 mV before (left-hand traces) and following a 10 min perfusion with 300 nM N-ACTX-Hv1b (right-hand traces). The dashed line
represents the zero current level. (B) Peak sodium currents are plotted against prepulse potential with currents normalised to the maximum con-
trol current. The amount of sodium current that is available for activation during the test pulse under control conditions (open circles) and
during 300 nM N-ACTX-Hv1b (closed circles) is shown. Note that, despite a hyperpolarising shift in hr, 96.8 þ 1.9% of maximum control cur-
rent could be achieved at a holding potential of 3135 mV in the presence of 300 nM N-ACTX-Hv1b. (C) Currents were normalised to the
maximum current recorded under control conditions (open circles) or in the presence of 300 nM N-ACTX-Hv1b (closed circles). Data in (C)
were ¢tted according to Eq. 2 described in Section 2. Data represent the mean þ S.E.M. of four experiments.
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Unfortunately, the presence of the four disul¢de bonds has
severely limited the e⁄cient production of synthetic or re-
combinant N-ACTXs in order to assess the e¡ect of mutations.
Therefore, the structure^function relationships, in particular
the channel-binding surface, of these toxins are at present
unknown. However, the mutagenesis study of Rogers et al.
[19] has identi¢ed a number of residues in the S3^S4 short
extracellular loop of domain IV of the sodium channel K-sub-
unit critical for the binding of scorpion K-toxins and sea ane-
mone toxins. Those residues identi¢ed as critical for binding
(Glu-1613, Glu-1616 and Lys-1617) are all charged, consistent
with the identi¢cation of several anionic and cationic residues
in scorpion K-toxins and sea anemone toxins that are crucial
for binding to neurotoxin receptor site 3 of the sodium chan-
nel [10,13]. Fletcher et al. [4] found that three cationic and two
anionic residues in N-ACTX-Hv1a can be superimposed on
similarly charged residues in the structures of anthopleurin-
B and Aah II, despite their lack of sequence homology and
totally di¡erent three-dimensional folds. They proposed that
Lys-3, Arg-5 and Asp-13 in N-ACTX-Hv1a provide a comple-
mentary surface to the residues identi¢ed in the S3^S4 loop of
domain IV. In the absence of mutational studies of N-ACTXs,
it would therefore appear that these three residues are impor-
tant for mammalian toxicity.
Importantly N-ACTX-Hv1a/Ar1 also show insect toxicity
and compete for LqhKIT-binding [11]. Despite their com-
pletely di¡erent three-dimensional folds, the structures of
N-ACTX-Hv1a and LqhKIT can be similarly overlaid such
that residues Lys-4, Arg-5 and Lys-19 in N-ACTX-Hv1a
superimpose very closely on residues Arg-64, Lys-62 and
Lys-8 in LqhKIT [11]. Interestingly, these residues are di¡er-
ent to those that superimpose on the structures of Aah II and
anthopleurin-B.
N-ACTX-Hv1b is unique amongst the N-ACTXs in that it
lacks insecticidal activity and shows a 15^30-fold reduction in
mammalian activity compared to N-ACTX-Hv1a/Ar1. Close
inspection of the primary structure reveals that a number of
charged amino acids at the N-terminus are not conserved
between N-ACTX-Hv1b and N-ACTX-Hv1a/Ar1 (see Fig. 2).
Since the two N-terminal cationic residues (Lys-4 and Arg-5)
are substituted by Ser-4 and Asp-5 in N-ACTX-Hv1b, this
lends support to the hypothesis that Lys-4 and Arg-5 are
important for insect activity. In addition, N-ACTX-Hv1b
shows considerably reduced activity on mammalian sodium
channels, consistent with the non-conserved mutation at posi-
tion 5.
Given that N-ACTXs target both mammalian and insect
sodium channels, they have considerable potential as tools
to aid in the investigation of structural requirements for
anti-insect versus anti-mammal activity. The residues that dif-
fer between N-ACTX-Hv1b and N-ACTX-Hv1a/Ar1 therefore
give us an unexpected insight into the residues that facilitate
interaction of N-ACTXs with insect sodium channels. This
raises the possibility that manipulation of key residues may
enable construction of a functional mirror-image of N-ACTX-
Hv1b, namely a N-ACTX that works on insect, but not verte-
brate, voltage-gated sodium channels. Such an insect-speci¢c
N-ACTX might be a useful biopesticide.
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